. Here, we demonstrate that axin is associated with GSK3 in the Xenopus embryo and we localize the GSK3-binding domain to a short region of axin. Binding of GSK3 correlates with the ability of axin to inhibit axial development and with the axisinducing activity of its dominant-negative form (DRGS).
Results and discussion
To gain an insight into the mode of action of axin, we tested its ability to interact with the known components of the Wnt signal transduction pathway. Xenopus early embryos were microinjected with axin mRNA, and Myc-tagged axin was precipitated from the embryonic lysates using tag-specific (9E10) monoclonal antibodies. Western blot analysis of the immunoprecipitates using GSK3-specific antibodies revealed the presence of GSK3 in the same protein complex as axin (Figure 1b, lanes 6,8) . To define which region of axin is involved in GSK3 binding, we carried out structure-function analyses. Axin contains two regions with similarity to other proteins: the RGS (regulator of G-protein signaling) domain and the Dishevelled homology (DIX) domain [5, 6] . Different deletion constructs of axin were overexpressed in early embryos (Figure 1a ,c) and their ability to associate with GSK3 was determined (Figure 1b) . GSK3 was efficiently bound to C1, C2, N1, ∆RGS, ∆RGS-N1, ∆RGS-C2 and ∆RGS-NC1 axin constructs (Figure 1b) , but not to ∆RGS-C3 (data not shown), C3, C4, C5 and ∆RGS-C4 constructs (Figure 1b) . All derivatives of axin were expressed at high levels and efficiently precipitated by the 9E10 antibodies (Figure 1c ). These observations indicate that the region of axin containing amino acids 527-724 is indispensable for GSK3 binding.
Although these experiments establish the biochemical association of axin and GSK3, they do not demonstrate whether this association is relevant to the function of axin during vertebrate axis determination. In amphibians, the dorsoventral axis is established with the formation of a dorsal inducing center or Spemann organizer [7] . Overexpression of axin in dorsovegetal blastomeres, which are known to give rise to the organizer, leads to inhibition of dorsal development [6] . We wanted to assess whether this ventralizing activity of axin is retained in those axin derivatives that no longer interact with GSK3. To that end, RNAs encoding different forms of axin ( Figure 1a) were injected into both dorsal blastomeres of the four-cell embryos, and their axial development was assessed morphologically and scored using the dorso-anterior index [8] . Whereas the wild-type, C1, C2 and N1 forms of axin had a pronounced ventralizing activity, C3, C4 and C5 constructs failed to significantly alter axial development (Figure 2a ,b,e and data not shown). Embryos injected with C3 and C4 constructs occasionally had anterior ectoderm deficiencies as well as defects in morphogenetic movements, which resulted in the average dorso-anterior index being lower than for uninjected embryos ( Figure 2e ). These experiments show that the same region that is necessary for GSK3 binding (amino acids 527-724) is also required for the ability of axin to cause ventralization. Thus, the biochemical association of axin and GSK3 correlates tightly with the functional activity of axin.
Although the formation of axin-GSK3 complex appears to be necessary for the ability of axin to inhibit dorsal development, it is clearly not sufficient, as this inhibition requires the presence of the intact RGS domain. A form of axin (∆RGS) lacking this domain has been shown to have an effect opposite to that of the wild-type axin [6] . Microinjection of ∆RGS mRNA into ventral blastomeres leads to induction of a complete secondary axis, supporting the view that the endogenous axin functions to repress dorsal development. We tested whether GSK3 binding correlates with the ability of different ∆RGS constructs ( Figure 1a ) to elicit secondary axis formation in ventral blastomeres ( Figure 2c ,d,f). ∆RGS-C2, ∆RGS-N1 and ∆RGS-NC1 retained the ability to induce a secondary axis, but ∆RGS-C3 and ∆RGS-C4 lost it. Thus, the same GSK3-binding region is required for the axis-inducing activity of ∆RGS. The simplest explanation for these observations is that ∆RGS sequesters GSK3, a negative regulator of axial development [9] [10] [11] , and thereby leads to induction of a secondary axis. As ∆RGS can still bind GSK3 (Figure 1b) , the RGS domain is required for a function of axin that is independent of GSK3 binding.
Our experiments show that the association between axin and GSK3 correlates tightly with the ability of axin to inhibit dorsal development and we have defined a conserved domain that is essential for axin's functional activity. To test the possibility that axin may regulate the 
kinase activity of GSK3, we studied GSK3-dependent phosphorylation of myelin basic protein (MBP) in immune complexes (Figure 3a,b) . Whereas the immunoprecipitated axin complex contained a kinase activity, no kinase activity was associated with a control C3 construct that does not bind GSK3, suggesting that MBP phosphorylation is dependent on GSK3. When compared with axin-associated GSK3, ∆RGS-associated GSK3 appeared to have somewhat lower kinase activity, although this difference may not be significant (Figure 3a,b) . In agreement with previously observed negative regulation of GSK3 by Wnt signaling [5, 12] , injection of Xwnt8 RNA resulted in a decrease in the total GSK3 activity and in axin-associated kinase activity (Figure 3a,b) . In contrast, overexpression of Xwnt8 (Figure 3a) or Xdsh (data not shown) did not change the amount of GSK3 complexed with Myctagged axin. These observations are consistent with a model in which Wnt signaling leads to down-regulation of axin-associated GSK3 activity.
To evaluate the possibility that axin interacts with other components of the Wnt pathway in addition to GSK3 and makes them available for regulation by the kinase, we assessed binding of axin to β-catenin, a potential substrate of GSK3 [13] . Embryos were injected with mRNAs encoding different axin constructs and lysed at the early gastrula stage for protein analysis. Immunoprecipitation with Myc-specific 9E10 antibodies followed by western blot analysis with anti-β-catenin antibodies has shown that β-catenin is also associated with axin ( Figure 3c ). We observed the binding of β-catenin to the wild-type axin, C1 and N1, but not to C3, C5 and ∆RGS axin derivatives ( Figure 3c ). As none of the ∆RGS constructs was associated with β-catenin, the RGS domain may be an important regulator of β-catenin binding. Consistent with the ability of axin to interact with β-catenin, axin caused a dosedependent suppression of the axis-inducing activity of β-catenin in ventral blastomeres (data not shown).
This study supports and extends the model in which Wnt signaling leads to inhibition of GSK3 activity, thus allowing β-catenin to translocate into the nucleus and associate with LEF/TCF factors to regulate target gene expression [5] . Our results suggest that axin may negatively regulate the Wnt pathway by bridging GSK3 with β-catenin and thus promoting β-catenin inactivation. Overall, this role for axin is similar to the proposed role for APC [14, 15] . At present, the involvement of APC in the Wnt pathway remains unclear because, in contrast to axin, the Xenopus homologue of APC stimulates, rather than inhibits, dorsal development [16] . We also provide an explanation for the dominant-negative effect of the ∆RGS construct. ∆RGS is capable of binding GSK3, but is unable to interact with β-catenin. Thus, ∆RGS may prevent GSK3 from phosphorylating β-catenin, thereby exerting a positive effect on Wnt signaling and dorsal development.
Our results, as well as those of an independent study [17] , reveal a biochemical link between axin and the Wnt pathway. As RGS domains are known to regulate Gprotein-coupled signaling by stimulating hydrolysis of the GTP bound to activated Gα subunits [18] , axin may Brief Communication 593 
U n i n j e c t e d X w n t 8 U n i n j e c t e d bridge G proteins and Wnt signaling. Moreover, the conserved DEP domain of Dishevelled [19] was proposed to be involved in the control of G-protein signaling. Although the activity of some Wnts, such as Xwnt5a, is known to be sensitive to G-protein inhibitors [20] , additional experiments are necessary to elucidate the role for G proteins in dorsal development.
Materials and methods

Embryos, DNA constructs and RNA microinjections
Construction of the different forms of axin cDNA (Figure 1a ) was based on the available restriction enzyme sites SacI, StuI, XbaI, SpeI, PstI, BglII and EcoRI. Capped synthetic RNAs were generated by in vitro transcription with SP6 RNA polymerase [21] . Eggs and embryos were obtained from Xenopus females and cultured in 0.1 × MMR (Marc's Modified Ringer) as described [22] . Embryonic stages were determined according to Nieuwkoop and Faber [23] . For microinjection, embryos were transferred to 3% Ficoll in 0.5 × MMR and injected at the four-cell stage with 10 nl of a solution containing 0.5-1 ng RNA from axin constructs or 5 pg Xwnt8 RNA. Injections were carried out in one ventral blastomere for secondary axis induction, two dorsal blastomeres for assaying the ventralizing activity of axin, and all four blastomeres for protein analysis. Embryonic phenotypes were scored morphologically at the equivalent of stage 35. The results were combined for at least three independent experiments.
Immunoprecipitation, western analysis and kinase assays
Injected embryos were lysed in 500 µl lysis buffer (0.5% NP40, 10 mM Tris-HCl at pH 7.5, 50 mM NaCl, 1 mM EDTA, 0.6 mM PMSF) when sibling embryos had developed to the early gastrula stages (stage 10 + -10.5). Lysates were cleared by centrifugation at 10,000 g for 10 min. Anti-Myc monoclonal antibody (20 µl 9E10 hybridoma supernatant) or 1 µg monoclonal anti-GSKβ antibodies (Transduction Labs) was incubated with the lysates for 2 h at room temperature. Protein A or Protein G-agarose (25 µl of 50% suspension) was added and incubated for an additional 40 min. The immunoprecipitates were washed three times with the lysis buffer and resuspended in a sample buffer. After separation in a 10% SDS-polyacrylamide gel, samples were electroblotted onto PVDF membrane (Millipore) at 100 V for 2 h. The membrane was blocked with 5% skim milk for 1 h and incubated overnight at 4°C with the 9E10, anti-GSK3β monoclonal or anti-β-catenin polyclonal antibodies. After washing three times with PBS plus 0.1% Tween-20, the membrane was incubated with horseradish peroxidase-conjugated secondary antibodies (Jackson) for 1 h. Peroxidase activity was visualized by enhanced chemiluminescence as described [24] . The membranes were stripped and re-probed after incubating for 15 min in 7 M guanidine-HCl, 50 mM Tris-HCl (pH 8.0), 20 mM DTT, 2 mM EDTA. For GSK3 activity determination, immunoprecipitates were washed three times with the lysis buffer and twice with 30 mM Tris-HCl, pH 7.5, 10 mM MgCl 2 . Immune complex kinase assays were carried out using [γ 32 P]ATP and MBP as described [25] . Phosphorylation of MBP was quantitated using Instant Image PhosphoImager. Relative kinase activity was calculated as a ratio of MBP phosphorylation (cpm × 100) to the amount of GSK3 measured by optical density. Each experiment was repeated at least three times.
